RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02179 RECBIO-B

Trading 06-30 15:12:16

4.700

+0.010

+0.21%

High4.700	Low4.700	Vol0.00
Open4.700	D1 Closing4.690	Amplitude0.00%
Mkt Cap2.94B	Tradable Cap2.15B	Total Shares626.00M
T/O0.00	T/O Rate0.00%	Tradable Shares458.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"RECBIO-B","latestPrice":4.7,"timestamp":1782799564813,"preClose":4.69,"halted":0,"volume":0,"delay":0,"changeRate":0.0021321961620468627,"floatShares":458092178,"shares":626000000,"eps":-1.3282238900783474,"marketStatus":"Trading","change":0.01,"latestTime":"06-30 15:12:16","open":4.7,"high":4.7,"low":4.7,"amount":0,"amplitude":0,"askPrice":5.15,"askSize":26500,"bidPrice":4.7,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":-1.246220502082206,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1782807000000},"marketStatusCode":2,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":4.69,"openAndCloseTimeList":[[1782783000000,1782792000000],[1782795600000,1782806400000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179/tweets","defaultTab":"tweets","newsList":[{"id":"2640975319","title":"Insiders Who Purchased CN¥15.3m Of Jiangsu Recbio Technology Stock May Not Have Expected 11% Tumble","url":"https://stock-news.laohu8.com/highlight/detail?id=2640975319","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640975319?lang=en_us&edition=fundamental","pubTime":"2026-06-03 10:58","pubTimestamp":1780455487,"startTime":"0","endTime":"0","summary":"Insiders who bought CN¥15.3m worth of Jiangsu Recbio Technology Co., Ltd.'s ( HKG:2179 ) stock at an average buy price...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CN","02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198719825","title":"Recbio AGM: Shareholders Endorse 2025 Accounts, 2026 Budget and Seven Other Resolutions with 99.99% Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1198719825","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198719825?lang=en_us&edition=fundamental","pubTime":"2026-05-28 22:03","pubTimestamp":1779977033,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (Recbio) secured near-unanimous shareholder support for all eight ordinary resolutions tabled at its Annual General Meeting (AGM) held on 28 May 2026 in Taizhou,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108705871","title":"Recbio Converts 141.95 Million Shares into H Shares, Optimising Capital Structure and Hong Kong Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1108705871","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108705871?lang=en_us&edition=fundamental","pubTime":"2026-05-05 16:44","pubTimestamp":1777970686,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (Recbio) disclosed its Monthly Return for April 2026, detailing a large-scale conversion of onshore equity into Hong Kong-listed H shares. Key Transaction   • On...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631326276","title":"Recbio completes full circulation, lists 141,953,489 converted H shares in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2631326276","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631326276?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:27","pubTimestamp":1777552078,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio completed full circulation of H shares, converting 141,953,489 unlisted shares into H shares.Converted H shares started trading in Hong Kong at 9:00 a.m. on April 30, 2026.H-share count rose to 458,092,178 from 316,138,689, lifting H shares to 73.17% of issued share capital from 50.5%.Domestic shares fell to 167,983,524 from 297,937,013, reducing their stake to 26.83% from 47.59%.Unlisted foreign shares dropped to zero from 12,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 30, 2026, and is solely responsible for the informa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL5qf2bf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189221928","title":"RECBIO-B Converts 141.95 Million Internal Shares to H Shares, Enlarging Hong Kong Float by 44.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189221928","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189221928?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:25","pubTimestamp":1777551926,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (RECBIO-B) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 30 April 2026, detailing a major adjustment to its share structure. On 29 April...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123809998","title":"RECBIO-B Completes Full Circulation of H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1123809998","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123809998?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:20","pubTimestamp":1777551618,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) has announced the completion of the conversion of a total of 142 million non-traded shares into H shares on April 29, 2026. The converted H shares commenced trading on the Stock Exchange of Hong Kong at 9:00 AM on April 30, 2026.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101039849","title":"RECBIO-B Shareholder Deposits Shares with Hong Kong Securities Clearing, Valued at HK$659 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1101039849","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101039849?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:46","pubTimestamp":1777509982,"startTime":"0","endTime":"0","summary":"It was learned that the latest data from the Hong Kong Stock Exchange shows that on April 29, a shareholder of RECBIO-B deposited shares with China Securities Depository and Clearing (Hong Kong). The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153953433","title":"Recbio Highlights 2025 ESG Progress: Strong Governance, Expanded Green Targets, and Enhanced Talent Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1153953433","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153953433?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:44","pubTimestamp":1777463091,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. released its fifth ESG report, detailing 2025 milestones across governance, climate action, product innovation and workforce development. Governance and Risk   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513090","title":"Jiangsu Recbio announces annual general meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513090","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513090?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:36","pubTimestamp":1777462599,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology will hold its 2025 annual general meeting in Taizhou, Jiangsu province on May 28, 2026.Shareholders will vote on 2025 financial accounts, 2026 financial budget, board work report, annual report.Meeting agenda also includes auditor appointment for 2026, 2026 director remuneration plan, 2025 profit distribution plan.Proposed change in use of proceeds will be put to a vote.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLbjkyMw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138300182","title":"瑞科生物2025年首度实现营收，净亏损6.1039亿元，核心疫苗进入商业化冲刺","url":"https://stock-news.laohu8.com/highlight/detail?id=1138300182","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138300182?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:27","pubTimestamp":1777462062,"startTime":"0","endTime":"0","summary":"江苏瑞科生物技术有限公司（RECBIO-B）公布截至2025年12月31日止年度业绩及相关信息。这是公司上市以来首度录得营收，全年实现收入人民币0.12726亿元（2024年：0），净亏损人民币6.1039亿元（2024年：5.61897亿元），经营与财务状况在推进研发和商业化的过程中发生显著结构转变。 一、经营与财务表现...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"瑞科生物2025年首度实现营收，净亏损6.1039亿元，核心疫苗进入商业化冲刺","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513986","title":"Jiangsu Recbio publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513986?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:25","pubTimestamp":1777461949,"startTime":"0","endTime":"0","summary":"Recbio published its 2025 annual report, highlighting transition from R&D-led model to commercialization.Shingles vaccine candidate REC610 moved into China marketing review, with CDE accepting filing in December 2025 under acceptance number CXSS2500145.HPV 9-valent vaccine candidate REC603 continued Phase III follow-up, with trial reaching 54-month visit stage.International expansion advanced via REC603 licensing deals with India-based Biological E and Russia-based Nanolek, with initial payments received.Commercial readiness work progressed, with Taizhou HPV facility designed for 20 million doses per year moving through pilot production to support future launch.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL5hKLSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178549258","title":"RECBIO-B Reports Unchanged Share Structure and Confirms Sufficient Public Float for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1178549258","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178549258?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:49","pubTimestamp":1775036972,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (RECBIO-B) submitted its monthly return to Hong Kong Exchanges and Clearing Limited on 01 April 2026, detailing share movements for the month ended 31 March 2026....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197825380","title":"Stock Track | RECBIO-B Plunges 25% Intraday After Reporting Widening Annual Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1197825380","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197825380?lang=en_us&edition=fundamental","pubTime":"2026-03-25 16:01","pubTimestamp":1774425673,"startTime":"0","endTime":"0","summary":"RECBIO-B's stock price plummeted 25% during intraday trading on Wednesday, following the release of the company's annual financial results for 2025.The biopharmaceutical company reported a loss...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622048359","title":"Jiangsu Recbio Technology's Loss Deepens in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2622048359","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622048359?lang=en_us&edition=fundamental","pubTime":"2026-03-25 09:50","pubTimestamp":1774403400,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology  posted a loss attributable to owners of 610.4 million yuan for 2025, widening from 562.4 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Loss per share came in at 1.15 yuan, compared with 1.16 yuan a year ago.Revenue was 12.7 million yuan, compared with nil revenue reported in 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141359722","title":"RECBIO-B Reports Annual Loss of 610 Million Yuan, Widening 8.54% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1141359722","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141359722?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:12","pubTimestamp":1774393945,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced its annual results for the period ending December 31, 2025. The company reported revenue of 12.726 million yuan. The loss attributable to shareholders was 610 million yuan,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622019859","title":"Jiangsu Recbio Technology FY Revenue RMB 12.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622019859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622019859?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:14","pubTimestamp":1774390458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nPLX0DE944:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153094557","title":"RECBIO-B Appoints Wei Qifang and Sun Jiaen as Joint Company Secretaries","url":"https://stock-news.laohu8.com/highlight/detail?id=1153094557","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153094557?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:44","pubTimestamp":1774363490,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced that Ms. Weng Meiyi has resigned from her positions as the company's Company Secretary, Authorized Representative under Rule 3.05 of the Listing Rules of The Stock Exchange...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155406531","title":"Recbio Announces Management Reshuffle: New Joint Company Secretaries and Authorised Representative Named","url":"https://stock-news.laohu8.com/highlight/detail?id=1155406531","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155406531?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:41","pubTimestamp":1774363306,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (“Recbio”) disclosed a series of corporate governance adjustments, effective 24 March 2026, aimed at strengthening board administration and compliance with Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095589","title":"Recbio appoints Wei Qifang and Suen Ka Yan as joint company secretaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095589","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621095589?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:39","pubTimestamp":1774363155,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio said Mei Yee Yung resigned as company secretary, authorized representative, and Hong Kong process agent, effective March 24, 2026.Qifang Wei and Ka Yan Suen were appointed joint company secretaries, with Wei also named authorized representative and Suen appointed Hong Kong process agent.Wei joined the group on October 26, 2025 and currently serves as assistant to the chairman and secretary to the board.His prior roles include global risk director at ZTE and managing director of the investment banking division at Guosen Securities.Suen is an assistant manager at SWCS Corporate Services Group  with more than nine years of corporate secretarial experience.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Techno","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL1YQQFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU1064131003.USD","02179","BK0058","BK0067","BK0103","000063","BK0183","BK0123","BK0090","LU1580142542.USD","BK0125","BK0000","BK0214","BK0276","BK1161","LU1781817850.SGD","LU2328871848.SGD","BK0167","BK0028","LU1328615791.USD","BK0148","BK0188","BK0030","BK0196","002736","LU1064130708.USD","BK0055","BK0171","BK0012","BK0018","LU2148510915.USD","BK0026"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102731298","title":"RECBIO-B (02179) Sets 24 March 2026 Board Meeting to Review FY 2025 Results and Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1102731298","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102731298?lang=en_us&edition=fundamental","pubTime":"2026-03-12 17:42","pubTimestamp":1773308576,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (RECBIO-B, 02179) announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s agenda includes: 1. Reviewing and approving the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0105},{"period":"3month","weight":0.1495},{"period":"6month","weight":0.1725},{"period":"1year","weight":-0.4101},{"period":"ytd","weight":0.1725}],"compareEarnings":[{"period":"1week","weight":-0.0312},{"period":"1month","weight":-0.0856},{"period":"3month","weight":-0.0711},{"period":"6month","weight":-0.1016},{"period":"1year","weight":-0.0518},{"period":"ytd","weight":-0.1016}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Jiangsu Recbio Technology Co Ltd is a China-based company engaged in vaccine research and development. The Company is still in the research and development stage. The Company's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009257},{"month":2,"riseRate":0.25,"avgChangeRate":-0.058747},{"month":3,"riseRate":0.25,"avgChangeRate":-0.071963},{"month":4,"riseRate":0.4,"avgChangeRate":-0.012446},{"month":5,"riseRate":0.2,"avgChangeRate":-0.039249},{"month":6,"riseRate":0.2,"avgChangeRate":-0.013129},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016314},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033938},{"month":9,"riseRate":0.25,"avgChangeRate":-0.012227},{"month":10,"riseRate":0.5,"avgChangeRate":0.027812},{"month":11,"riseRate":0,"avgChangeRate":-0.140794},{"month":12,"riseRate":0.75,"avgChangeRate":0.059254}],"exchange":"SEHK","name":"RECBIO-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RECBIO-B,02179,RECBIO-B股票,RECBIO-B股票老虎,RECBIO-B股票老虎国际,RECBIO-B行情,RECBIO-B股票行情,RECBIO-B股价,RECBIO-B股市,RECBIO-B股票价格,RECBIO-B股票交易,RECBIO-B股票购买,RECBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}